Viewing Study NCT02849756


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-03-01 @ 12:04 PM
Study NCT ID: NCT02849756
Status: COMPLETED
Last Update Posted: 2019-07-29
First Post: 2016-07-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Future of the Older Patients After Intensive Care Unit
Sponsor: Hôpital NOVO
Organization:

Study Overview

Official Title: Future of the Older Patients After Intensive Care Unit
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DAAR
Brief Summary: Estimate the future six months after the admission in an intensive care unit of the patients of 85 and more years old in terms of autonomy.
Detailed Description: The diverse studies published on the future of the elderly hospitalized in resuscitation place the limit very low, between 65 and 80 years. The feeling of a very bad forecast at these extreme ages pulls nevertheless a filter in the admission in ICU which has this day no scientific justification. The knowledge of the evolution after the hospitalization of these older patients can help to make certain decisions concerning as well the admission of these patients in ICU as the realization of invasive treatments.

After informal interrogation of numerous intensivists, it seems to take shape a bar around 85 years beyond which the forecast would be worse without more proof what consolidated the choice of this limit.

The reserved scores were already used in similar studies (simplified ALD).

Primary purpose :

* Describe the survival and the evolution of the quality of life after a stay in resuscitation for very old patients.
* The quality of life will be studied through a score of autonomy: the simplified ALD score.

The population will be described in general then by age bracket (more or less of 90 years old), according to the length of stay in ICU, the heavy treatments (artificial ventilation, renal replacement therapy) practiced, the initial gravity (score IGS 2). The impact of possible decisions of Limitation or Stop of Therapeutic Activates will also be taken into account.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: